, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. Mempel M, Ronet C, Suarez F, Gilleron M, Puzo G, Van Kaer L, Lehuen A, Kourilsky P, Gachelin G (2002) J Immunol 168(1): 365-71
    › Primary publication · 11751982 (PubMed)
  2. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC, Wilson JM, Schmieg J, Kronenberg M, Nakayama T, Taniguchi M, Koezuka Y, Tsuji M (2002) J Exp Med 195(5): 617-24
    › Primary publication · 11877484 (PubMed) · PMC2193764 (PubMed Central)
  3. Major histocompatibility complex class I-restricted antigen processing and presentation. Van Kaer L (2002) Tissue Antigens 60(1): 1-9
    › Primary publication · 12366777 (PubMed)
  4. Immunotherapy with ligands of natural killer T cells. Wilson MT, Singh AK, Van Kaer L (2002) Trends Mol Med 8(5): 225-31
    › Primary publication · 12067632 (PubMed)
  5. IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. Hayakawa Y, Takeda K, Yagita H, Smyth MJ, Van Kaer L, Okumura K, Saiki I (2002) Blood 100(5): 1728-33
    › Primary publication · 12176894 (PubMed)
  6. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD (2002) J Immunol 168(8): 4173-83
    › Primary publication · 11937578 (PubMed)
  7. Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, Lassmann H, Herbelin A, Lehuen A, Liblau RS (2002) J Immunol 168(12): 6007-11
    › Primary publication · 12055208 (PubMed)
  8. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, Unutmaz D (2002) J Exp Med 195(7): 869-79
    › Primary publication · 11927631 (PubMed) · PMC2193731 (PubMed Central)
  9. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. Faveeuw C, Angeli V, Fontaine J, Maliszewski C, Capron A, Van Kaer L, Moser M, Capron M, Trottein F (2002) J Immunol 169(2): 906-12
    › Primary publication · 12097395 (PubMed)
  10. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L (2001) Nat Med 7(9): 1052-6
    › Primary publication · 11533710 (PubMed)